Literature DB >> 27456830

Role of Serum Amyloid A, Granulocyte-Macrophage Colony-Stimulating Factor, and Bone Marrow Granulocyte-Monocyte Precursor Expansion in Segmented Filamentous Bacterium-Mediated Protection from Entamoeba histolytica.

Stacey L Burgess1, Mahmoud Saleh1, Carrie A Cowardin1, Erica Buonomo1, Zannatun Noor1, Koji Watanabe2, Mayuresh Abhyankar1, Stephane Lajoie3, Marsha Wills-Karp3, William A Petri4.   

Abstract

Intestinal segmented filamentous bacteria (SFB) protect from ameba infection, and protection is transferable with bone marrow dendritic cells (BMDCs). SFB cause an increase in serum amyloid A (SAA), suggesting that SAA might mediate SFB's effects on BMDCs. Here we further explored the role of bone marrow in SFB-mediated protection. Transient gut colonization with SFB or SAA administration alone transiently increased the H3K27 histone demethylase Jmjd3, persistently increased bone marrow Csf2ra expression and granulocyte monocyte precursors (GMPs), and protected from ameba infection. Pharmacologic inhibition of Jmjd3 H3K27 demethylase activity during SAA treatment or blockade of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling in SFB-colonized mice prevented GMP expansion, decreased gut neutrophils, and blocked protection from ameba infection. These results indicate that alteration of the microbiota and systemic exposure to SAA can influence myelopoiesis and susceptibility to amebiasis via epigenetic mechanisms. Gut microbiota-marrow communication is a previously unrecognized mechanism of innate protection from infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27456830      PMCID: PMC5038085          DOI: 10.1128/IAI.00316-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production.

Authors:  Shinjiro Hamano; Amon Asgharpour; Suzanne E Stroup; Thomas A Wynn; Edward H Leiter; Eric Houpt
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 2.  Epigenetic control of myeloid cell differentiation, identity and function.

Authors:  Damiana Álvarez-Errico; Roser Vento-Tormo; Michael Sieweke; Esteban Ballestar
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

Review 3.  Epigenetic modifications of the immune system in health and disease.

Authors:  Yuuki Obata; Yukihiro Furusawa; Koji Hase
Journal:  Immunol Cell Biol       Date:  2015-02-10       Impact factor: 5.126

Review 4.  Innate IL-17 and IL-22 responses to enteric bacterial pathogens.

Authors:  Stephen J Rubino; Kaoru Geddes; Stephen E Girardin
Journal:  Trends Immunol       Date:  2012-02-17       Impact factor: 16.687

5.  Therapeutic Role of Interleukin 22 in Experimental Intra-abdominal Klebsiella pneumoniae Infection in Mice.

Authors:  Mingquan Zheng; William Horne; Jeremy P McAleer; Derek Pociask; Taylor Eddens; Misty Good; Bin Gao; Jay K Kolls
Journal:  Infect Immun       Date:  2016-01-04       Impact factor: 3.441

Review 6.  Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF.

Authors:  Margarita Martinez-Moczygemba; David P Huston
Journal:  J Allergy Clin Immunol       Date:  2003-10       Impact factor: 10.793

7.  Commensal microbiota stimulate systemic neutrophil migration through induction of serum amyloid A.

Authors:  Michelle Kanther; Sarah Tomkovich; Sun Xiaolun; Melinda R Grosser; Jaseol Koo; Edward J Flynn; Christian Jobin; John F Rawls
Journal:  Cell Microbiol       Date:  2014-01-24       Impact factor: 3.715

Review 8.  Trained immunity: A program of innate immune memory in health and disease.

Authors:  Mihai G Netea; Leo A B Joosten; Eicke Latz; Kingston H G Mills; Gioacchino Natoli; Hendrik G Stunnenberg; Luke A J O'Neill; Ramnik J Xavier
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

9.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages.

Authors:  Francesca De Santa; Vipin Narang; Zhei Hwee Yap; Betsabeh Khoramian Tusi; Thomas Burgold; Liv Austenaa; Gabriele Bucci; Marieta Caganova; Samuele Notarbartolo; Stefano Casola; Giuseppe Testa; Wing-Kin Sung; Chia-Lin Wei; Gioacchino Natoli
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

10.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

View more
  14 in total

1.  Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.

Authors:  Renay Ngobeni; Amidou Samie; Shannon Moonah; Koji Watanabe; William A Petri; Carol Gilchrist
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

Review 2.  Host-microbiota interactions: epigenomic regulation.

Authors:  Vivienne Woo; Theresa Alenghat
Journal:  Curr Opin Immunol       Date:  2017-01-16       Impact factor: 7.486

3.  Entamoeba histolytica: Host parasite interactions at the colonic epithelium.

Authors:  Steve Cornick; Kris Chadee
Journal:  Tissue Barriers       Date:  2017-01-02

4.  Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis.

Authors:  Koji Watanabe; Carol A Gilchrist; Md Jashim Uddin; Stacey L Burgess; Mayuresh M Abhyankar; Shannon N Moonah; Zannatun Noor; Jeffrey R Donowitz; Brittany N Schneider; Tuhinur Arju; Emtiaz Ahmed; Mamun Kabir; Masud Alam; Rashidul Haque; Patcharin Pramoonjago; Borna Mehrad; William A Petri
Journal:  PLoS Pathog       Date:  2017-08-17       Impact factor: 6.823

Review 5.  Parasitic Protozoa and Interactions with the Host Intestinal Microbiota.

Authors:  Stacey L Burgess; Carol A Gilchrist; Tucker C Lynn; William A Petri
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

6.  Gut microbiome communication with bone marrow regulates susceptibility to amebiasis.

Authors:  Stacey L Burgess; Jhansi L Leslie; Jashim Uddin; David N Oakland; Carol Gilchrist; G Brett Moreau; Koji Watanabe; Mahmoud Saleh; Morgan Simpson; Brandon A Thompson; David T Auble; Stephen D Turner; Natasa Giallourou; Jonathan Swann; Zhen Pu; Jennie Z Ma; Rashidul Haque; William A Petri
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

7.  Microbiota Inhibit Epithelial Pathogen Adherence by Epigenetically Regulating C-Type Lectin Expression.

Authors:  Vivienne Woo; Emily M Eshleman; Taylor Rice; Jordan Whitt; Bruce A Vallance; Theresa Alenghat
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

8.  Intestinal parasitic infection alters bone marrow derived dendritic cell inflammatory cytokine production in response to bacterial endotoxin in a diet-dependent manner.

Authors:  Stacey L Burgess; Akihiko Oka; Bo Liu; David T Bolick; David Noah Oakland; Richard L Guerrant; Luther Bartelt
Journal:  PLoS Negl Trop Dis       Date:  2019-07-01

Review 9.  Parasite-Microbiota Interactions With the Vertebrate Gut: Synthesis Through an Ecological Lens.

Authors:  Jacqueline M Leung; Andrea L Graham; Sarah C L Knowles
Journal:  Front Microbiol       Date:  2018-05-14       Impact factor: 5.640

10.  Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice.

Authors:  Krysta M Felix; Ivan A Jaimez; Thuy-Vi V Nguyen; Heqing Ma; Walid A Raslan; Christina N Klinger; Kristian P Doyle; Hsin-Jung J Wu
Journal:  Front Cell Infect Microbiol       Date:  2018-04-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.